EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDO

• Status: Completed
• Trial end date: 2013-06-01

Summary

The hypothesis is that Etoricoxib act as an adjuvant to SRP in alleviating periodontal inflammation by:

1. improving clinical periodontal parameters and,

2. improving the salivary SOD levels.

• Phase: Phase 4

Details

• Lead Sponsor: Tatyasaheb Kore Dental College
• Treatments: Cyclooxygenase 2 Inhibitors; Etoricoxib; Superoxide Dismutase